1.Pancreas cancer - Is chemotherapy necessary?.
Korean Journal of Medicine 1999;57(4):740-749
No abstract available.
Drug Therapy*
;
Pancreas*
;
Pancreatic Neoplasms*
4.Novel Palliative Chemotherapy in Patients with Metastatic Pancreatic Cancer: PEGPH20.
The Korean Journal of Gastroenterology 2018;71(4):244-245
No abstract available.
Drug Therapy*
;
Humans
;
Pancreatic Neoplasms*
6.Cystic neoplasms of the pancreas: current diagnostic modalities and management.
Dennis Z W NG ; Brian K P GOH ; Elizabeth H W THAM ; Stephanie M YOUNG ; London Lucien P J OOI
Annals of the Academy of Medicine, Singapore 2009;38(3):251-259
Cystic neoplasm of the pancreas is a relatively uncommon condition covering a wide spectrum of pathology. The increasing incidence as a result of routine imaging tests in asymptomatic patients presents a diagnostic and therapeutic problem to the clinician. This paper discusses the role of the various investigative modalities in the management of cystic neoplasia of the pancreas.
Cystadenoma
;
diagnosis
;
therapy
;
Pancreatic Neoplasms
;
diagnosis
;
therapy
7.The guideline for neoadjuvant therapy of pancreatic cancer in China (2020 edition).
Chinese Journal of Surgery 2020;58(9):657-667
In order to improve the overall treatment level of pancreatic cancer in China, Study Group of Pancreatic Surgery in China Society of Surgery of Chinese Medical Association and Pancreatic Disease Committee of China Research Hospital Association have formulated the guideline for neoadjuvant therapy of pancreatic cancer in China (2020 edition). Based on the GRADE system, the guideline has conducted a discussion on the indication, regimen selection, therapeutic effect evaluation, pathological diagnosis and surgery strategy, etc. This guideline has quantified the evidence level of the current clinical researches and provided recommendations for the clinical practice in the neoadjuvant therapy of pancreatic cancer. The guideline has highlighted the role of multiple disciplinary team and represented the conversion of treatment concept in pancreatic cancer. Neoadjuvant therapy has prolonged the survival of the part of pancreatic cancer patients. However, more high-quality clinical researches are in urgent need to improve the level of evidence, optimize the clinical practice and improve the survival of patients.
China
;
Humans
;
Neoadjuvant Therapy
;
Pancreatic Neoplasms
;
therapy
8.Guidelines for the diagnosis and treatment of pancreatic cancer in China(2021).
Chinese Journal of Surgery 2021;59(7):561-577
The incidence of pancreatic cancer has been rising worldwide,while its clinical diagnosis and treatment remain a great challenge. To present the update and improvements in the clinical diagnosis and treatment of pancreatic cancer in recent years, Chinese Pancreatic Surgery Association,Chinese Society of Surgery,Chinese Medical Association updated "Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021)" based on the Guideline of Management of Pancreatic Cancer in China which had been published in 2014. This updated guideline was formulated after reviewing evidence-based and problem-oriented literatures published from 2015-2021,mainly focusing on highlight issues regarding diagnosis and surgical treatment of pancreatic cancer,conversion strategies for locally advanced pancreatic cancer,treatment of pancreatic cancer with oligo metastasis,adjuvant and neoadjuvant therapy,standardized processing of surgical specimens and evaluation of surgical margin status,systemic treatment for unresectable pancreatic cancer,genetic testing,as well as postoperative follow up of patients with pancreatic cancer. Forty recommendation items were finally proposed based on the above issues,and the quality of evidence and strength of recommendations were graded using the Grades of Recommendation,Assessment,Development,and Evaluation system. This guideline aims to improve the ability of clinical diagnosis and therapy,especially surgical treatment of pancreatic cancer in China,and furtherly improve the prognosis of pancreatic cancer patients.
China
;
Humans
;
Neoadjuvant Therapy
;
Pancreatic Neoplasms/therapy*
10.Ten directions for improving clinical therapeutic effect of pancreatic cancer in the future.
Liang LIU ; Wen Quan WANG ; Wen Hui LOU
Chinese Journal of Surgery 2022;60(1):10-16
Pancreatic cancer is one of the most malignant digestive system tumors. In the recent decade, the effect of diagnosis and treatment of pancreatic cancer has improved due to the renewal of treatment concept and the popularization of effective treatment. However, the overall efficacy of pancreatic cancer is still dismal and the 5-year survival rate is only about 10%. Further improving the diagnosis and treatment of pancreatic cancer is the top priority of oncology research and clinical practice. Based on past clinical and scientific research experience, the authors have proposed ten hot spots and future directions for a reference, which focusing on early prevention, early diagnosis, and early treatment of pancreatic cancer, molecular typing and precise treatment, new drug development and regimen combination, surgical technology and strategy change, model establishment and database development, as well as innovation of traditional Chinese medicine and breakthrough of treatment concept. A breakthrough in the diagnosis and treatment of pancreatic cancer in the next ten years is raising hope, when doctors can truly prevent and control pancreatic cancer.
Humans
;
Pancreatic Neoplasms/therapy*
;
Treatment Outcome